CNIPA.AI
Sign In

All tools

Patent applicant records

APPLICANTS

苏州拓维生物技术有限公司

Browse source applicant names and unchanged name fields from imported patent records.

These are name-based results, not verified legal entities. Identical names may refer to different people or organizations; aliases and historical names are not merged.

This name was extracted from a distinct applicant node in the source XML.

1 indexed patent records

Patent counts refer to distinct records held by this site, not an applicant’s complete portfolio. A joint name field is not a single company.

Verified corpus date coverage and last import time are not currently available. Publication dates on patent records are not import dates. Cached directory results may lag behind new imports.

Search the local original applicant field containing this full text. Results may include joint lists or longer names; this is not an exact identity search.

Search patents with this applicant condition
Open patent writing
№ CN122973396AInvention
Unknown

一种高稳定性的自身免疫/代谢性肺纤维化合并2型糖尿病小鼠模型的构建方法和应用

本发明公开了一种高稳定性的自身免疫/代谢性肺纤维化合并2型糖尿病小鼠模型的构建方法和应用。所述方法包括：以高脂饲料喂养4~5周龄C57BL/6J小鼠6周；再于第7周开始以微量雾化给药系统进行苯并芘气管雾化吸入，剂量为0.5~1.0 mg/kg，每周2次，持续4周；雾化结束后继续维持高脂饮食至第14周。本发明模型在同一动物上同时呈现2型糖尿病代谢特征、自身免疫活化及进行性肺纤维化三重表型，生存率高，病变呈慢性持续进展，且对临床药物反应灵敏，可用于自身免疫/代谢性肺纤维化合并2型糖尿病共病的发病机制研究及抗纤维化药物、免疫代谢调节药物的临床前药效学筛选与评价。

❖苏州拓维生物技术有限公司李恒; 张立民Oct 27, 2026§ 1/10 ClaimsA61K 31/015 (2006.01), A01K 67/02 (2006.01), A61K 49/00 (2006.01)